Ignatia Amara Pellet
FDA Label NDC 0220-2613

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Boiron for the product Ignatia Amara (NDC 0220-2613). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, use, stop use and ask a doctor if, if pregnant or breast-feeding,, directions, other information, inactive ingredients, questions, comments?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Ignatia amara HPUS
6X, 12X, 30X, 6C, 9C, 12C, 15C, 30C, 200CK, 1M, 10M, 50M, 1CM

Use

Apprehension, hypersensitivity to stress*

Stop Use And Ask A Doctor If

symptoms persist for more than 3 days or worsen.

If Pregnant Or Breast-Feeding,

ask a health professional before use.

Directions

5 pellets 3 times a day until symptoms are relieved.

Other Information

Do not use if pellet dispenser seal is broken.
contains approx. 80 pellets

Inactive Ingredients

lactose, sucrose

*

These "Uses" have not been evaluated by the FDA.

* Please review the disclaimer below.